NUVA - NuVasive, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
53.31
+1.09 (+2.09%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close52.22
Open51.97
Bid0.00 x 0
Ask0.00 x 0
Day's Range51.93 - 53.33
52 Week Range44.62 - 81.68
Volume533,205
Avg. Volume781,645
Market Cap2.733B
Beta0.69
PE Ratio (TTM)35.54
EPS (TTM)1.50
Earnings DateMay 1, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est62.73
Trade prices are not sourced from all markets
  • PR Newswireyesterday

    NuVasive Sponsors AANS 2018, Hosts Workshops And Presentations On Latest Innovations

    SAN DIEGO, April 24, 2018 /PRNewswire/ -- NuVasive, Inc. (NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the Company is a sponsor of the American Association of Neurological Surgeons (AANS) Annual Scientific meeting being held April 28-May 2, 2018, in New Orleans, at the Earnest N. Morial Convention Center. NuVasive will host a hands-on workshop featuring the latest advances in Lateral Single-Position surgery, technology to reduce OR radiation and developments in 3D-printed implants. The NuVasive Industry Lunch and Learn Workshop, Single-Position Lateral Surgery Solutions to Treat L4-S1, Featuring Advanced 3D-Printed Implants and LessRay® Radiation Emission Reduction Technology, by Kaveh Khajavi, M.D., Robert Issacs, M.D. and Juan Uribe, M.D., will take place on Monday, April 30 from 1:10-1:55 p.m. in Room 272-273.

  • GlobeNewswire7 days ago

    New Research: Key Drivers of Growth for NuVasive, Apptio, Apollo Investment, Uranium Energy, AECOM, and US Foods Holding — Factors of Influence, Major Initiatives and Sustained Production

    NEW YORK, April 19, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ...

  • See what the IHS Markit Score report has to say about NuVasive Inc.
    Markit15 days ago

    See what the IHS Markit Score report has to say about NuVasive Inc.

    NuVasive Inc NASDAQ/NGS:NUVA

  • PR Newswire15 days ago

    NuVasive Announces Conference Call And Webcast Of First Quarter 2018 Results

    SAN DIEGO, April 10, 2018 /PRNewswire/ -- NuVasive, Inc. (NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced today that its first quarter 2018 earnings announcement will take place on Tuesday, May 1, 2018, after the close of the market. NuVasive will hold a conference call on Tuesday, May 1, 2018, at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results of its financial performance for the first quarter 2018. The dial-in numbers are 1-877-407-9712 for domestic callers and 1-201-689-8323 for international callers.

  • PR Newswire20 days ago

    NuVasive Sponsors ISASS 2018, Hosts Workshops And Presentations

    SAN DIEGO, April 5, 2018 /PRNewswire/ -- NuVasive, Inc. (NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced the Company is a sponsor of the International Society for the Advancement of Spine Surgery, 18th Annual Conference (ISASS) being held April 11-13, 2018, in Toronto, at the Metro Toronto Convention Centre. NuVasive will host a hands-on workshop featuring the latest advances in Lateral Single-Position solutions, as well as a number of podium presentations at ISASS 2018.

  • PR Newswire23 days ago

    NuVasive Portfolio Now Includes ALIF Retractor Platform For Lateral And Supine Approaches

    SAN DIEGO, April 2, 2018 /PRNewswire/ -- NuVasive, Inc. (NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the launch of ALIF (Anterior Lumbar Interbody Fusion) Access, the Company's first-ever MAS® (Maximum Access Surgery) ALIF retractor platform for both lateral and supine spine surgery approaches. The retractor system's features help retain the characteristics of a traditional ALIF while giving surgeons options for either a lateral or supine approach based on patient need.

  • PR Newswire27 days ago

    Research Shows NuVasive Porous PEEK Structure Maintains High Porosity After Impaction

    Results of Porous PEEK™ impaction durability study now available in The Spine Journal SAN DIEGO , March 29, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, ...

  • Why Is NuVasive (NUVA) Up 4.6% Since Its Last Earnings Report?
    Zacks29 days ago

    Why Is NuVasive (NUVA) Up 4.6% Since Its Last Earnings Report?

    NuVasive (NUVA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • Orthopedic Device Market Gains Momentum: 3 Stocks in Focus
    Zackslast month

    Orthopedic Device Market Gains Momentum: 3 Stocks in Focus

    The orthopedics market holds immense potential for investors who are keen on the healthcare space for long-term gains.

  • See what the IHS Markit Score report has to say about NuVasive Inc.
    Markitlast month

    See what the IHS Markit Score report has to say about NuVasive Inc.

    Short interest is moderate for NUVA with between 5 and 10% of shares outstanding currently on loan. This represents an increase in short interest as investors who seek to profit from falling equity prices added to their short positions on February 9.

  • NuVasive Gains From International Business Amid Pricing Woes
    Zacks2 months ago

    NuVasive Gains From International Business Amid Pricing Woes

    Sturdy performance of NuVasive's (NUVA) international business with more than 20% growth for the fifth consecutive quarter raises optimism among investors

  • PR Newswire2 months ago

    NuVasive to Participate in Investor Events in March 2018

    NuVasive, Inc. (NUVA) is a world leader in minimally invasive, procedurally-integrated spine solutions. From complex spinal deformity to degenerative spinal conditions, NuVasive is transforming spine surgery with innovative technologies designed to deliver reproducible and clinically proven surgical outcomes.

  • Thomson Reuters StreetEvents2 months ago

    Edited Transcript of NUVA earnings conference call or presentation 26-Feb-18 9:30pm GMT

    Q4 2017 NuVasive Inc Earnings Call

  • NuVasive (NUVA) Meets Q4 Earnings Estimates, Issues '18 View
    Zacks2 months ago

    NuVasive (NUVA) Meets Q4 Earnings Estimates, Issues '18 View

    NuVasive (NUVA) gains on continued growth in international business in Q4.

  • NuVasive Sees a Stronger 2018
    Motley Fool2 months ago

    NuVasive Sees a Stronger 2018

    The spinal surgical equipment specialist saw growth flatten out but still posted its first $1 billion sales year.

  • Associated Press2 months ago

    NuVasive meets 4Q profit forecasts

    On a per-share basis, the San Diego-based company said it had profit of 46 cents. Earnings, adjusted for one-time gains and costs, were 56 cents per share. The results met Wall Street expectations. The ...

  • PR Newswire2 months ago

    NuVasive Reports Fourth Quarter and Full Year 2017 Financial Results

    Company Provides Financial Performance Guidance for 2018 SAN DIEGO , Feb. 26, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, transforming spine surgery with ...

  • ACCESSWIRE2 months ago

    NuVasive, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / February 26, 2018 / NuVasive, Inc. (NASDAQ: NUVA ) will be discussing their earnings results in their Q4 Earnings Call to be held on February 26, 2018 at 4:30 PM Eastern Time. ...

  • Does NuVasive Inc’s (NASDAQ:NUVA) Recent Track Record Look Strong?
    Simply Wall St.2 months ago

    Does NuVasive Inc’s (NASDAQ:NUVA) Recent Track Record Look Strong?

    After reading NuVasive Inc’s (NASDAQ:NUVA) most recent earnings announcement (30 September 2017), I found it useful to look back at how the company has performed in the past and compareRead More...

  • International Business Aids NuVasive, Pricing Woe Remains
    Zacks2 months ago

    International Business Aids NuVasive, Pricing Woe Remains

    NuVasive (NUVA) plans to merge its U.S. Commercial and International sales functions into a global commercial organization. Also, several recent FDA approvals are encouraging.

  • NuVasive's SpineTRACK Registry Gains New CMS Designation
    Zacks2 months ago

    NuVasive's SpineTRACK Registry Gains New CMS Designation

    NuVasive's (NUVA) receipt of the QCDR designation for its SpineTRACK buoys optimism for the stock. This achievement might add value to cushion its efforts to provide systems-based spine solutions.

  • PR Newswire2 months ago

    NuVasive SpineTRACK Registry Named Qualified Clinical Data Registry By Centers Of Medicare And Medicaid Services

    SAN DIEGO, Feb. 20, 2018 /PRNewswire/ -- NuVasive, Inc. (NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced that the Company's SpineTRACK Registry has received the designation of Qualified Clinical Data Registry (QCDR) by the Centers of Medicare and Medicaid Services (CMS) for the 2018 Merit-based Incentive Payment System (MIPS) reporting year. As a result, SpineTRACK participants can now use the platform to earn Medicare payment incentives.

  • GlobeNewswire2 months ago

    Research Report Identifies Ichor, TASER International, Premier, NuVasive, Verastem, and BLACKLINE INC with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement

    NEW YORK, Feb. 09, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Ichor ...

  • PR Newswire2 months ago

    John DeFord To Join NuVasive Board Of Directors

    SAN DIEGO, Feb. 8, 2018 /PRNewswire/ -- NuVasive, Inc. (NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced the appointment of John A. DeFord, Ph.D. to the Company's Board of Directors, effective upon the filing of the Company's Form 10-K with the Securities and Exchange Commission. Dr. DeFord has more than 25 years of experience in the medical device industry, with particular expertise overseeing clinical advancement through innovative R&D and technology-based initiatives.

  • See what the IHS Markit Score report has to say about NuVasive Inc.
    Markit3 months ago

    See what the IHS Markit Score report has to say about NuVasive Inc.

    Additionally, this was an improvement in sentiment as investors who seek to profit from falling equity prices reduced their short positions on February 5. Index (PMI) data, output in the Healthcare sector is rising.